Changeflow GovPing Healthcare & Life Sciences Animal Cell Growth Promoter Uses Embryonic Memb...
Routine Notice Added Final

Animal Cell Growth Promoter Uses Embryonic Membrane Extract

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

USPTO published patent application US20260109945A1 on April 23, 2026, filed June 9, 2025 (Application No. 19231865), titled 'Animal Cell Growth Promoter, Medium for Culturing Animal Cells, and Device for Culturing Animal Cells.' The invention covers a novel animal cell growth promoter comprising a culture supernatant of an embryonic membrane derived from avian or reptilian fertilized eggs. Inventors: Ikko KAWASHIMA, Yuki Hanyu, Keita Fukumoto. CPC classifications: C12N 5/0602, C12M 29/26, C12M 41/46, C12N 2502/025, C12N 2521/00. The application provides intellectual property protection for biotechnological methods of promoting animal cell growth using embryonic membrane-derived culture supernatant.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 264 changes logged to date.

What changed

USPTO published patent application US20260109945A1, covering a novel animal cell growth promoter that uses a culture supernatant derived from embryonic membranes of avian or reptilian fertilized eggs. The application also discloses a culture medium incorporating this promoter and a device for culturing animal cells using the same.

For biotechnology and pharmaceutical companies engaged in cell culture research and manufacturing, this published application represents potential prior art for similar inventions and may warrant monitoring for competitive intelligence purposes. The use of embryonic membrane extracts from avian or reptilian eggs as growth promoters represents a novel approach in cell culture technology.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

ANIMAL CELL GROWTH PROMOTER, MEDIUM FOR CULTURING ANIMAL CELLS, AND DEVICE FOR CULTURING ANIMAL CELLS

Application US20260109945A1 Kind: A1 Apr 23, 2026

Inventors

Ikko KAWASHIMA, Yuki Hanyu, Keita Fukumoto

Abstract

The present invention aim at providing a novel animal cell growth promoter. Specifically, a culture supernatant of an embryonic membrane derived from an avian or reptilian fertilized egg is use as an animal cell growth promoter. For example, by adding, to an animal cell culture medium, an animal cell growth promoter comprising, as an active ingredient, a culture supernatant of an embryonic membrane derived from an avian or reptilian fertilized egg, the animal cell growth can be promoted.

CPC Classifications

C12N 5/0602 C12M 29/26 C12M 41/46 C12N 2502/025 C12N 2521/00

Filing Date

2025-06-09

Application No.

19231865

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 23rd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Biotechnology companies Pharmaceutical companies Manufacturers
Industry sector
3254.1 Biotechnology
Activity scope
Patent application Cell culture technology Biotechnology research
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Biotechnology Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!